Maryland House Bill HB1275

Maryland 2022 Regular Session

• Introduced: 2/11/22
• Refer: 2/11/22

Caption

Pharmacy Benefits Managers - Contracts With Pharmacy Services Administrative Organizations

Impact

The introduction of HB 1275 is expected to have a significant impact on the operations of pharmacy benefits managers and their contractual relationships with pharmacy services administrative organizations. By mandating disclosures prior to any contract amendment and prohibiting certain practices that could lead to reduced payments for services, the bill aims to protect pharmacies from potential financial discrepancies. This legislative change will likely promote fairer practices within the insurance industry and create a more predictable financial environment for pharmacies.

Summary

House Bill 1275 focuses on regulating contracts between pharmacy benefits managers and pharmacy services administrative organizations. The bill aims to enhance transparency and ensure that pharmacy benefits managers disclose essential information regarding their contracts. Specifically, it requires these managers to provide details about reimbursement rates, procedures for verifying benefits, and the dispute resolution process when entering into agreements with pharmacy services organizations. Additionally, substantial changes to contracts cannot take effect without prior disclosure to the involved parties, thereby enhancing clarity and cooperation.

Contention

Notable points of contention surrounding HB 1275 may include debates about the administrative burden it places on pharmacy benefits managers. Some industry stakeholders may argue that the requirement for detailed disclosures and the prohibition on certain payment reductions adds unnecessary complexity to existing processes. Conversely, supporters of the bill argue that such measures are essential for consumer protection and ensure that pharmacies can operate fairly and sustainably within the healthcare system.